Century Therapeutics
IPSC
Century Therapeutics (IPSC) news
Recent news
Centerpoint Energy: Jefferies cuts target price to $49 from $50
Jefferies has revised its target price for Centerpoint Energy (CEN) to $49 from $50, reflecting a minor downward adjustment in its valuation outlook for the utility company. The move comes amid ongoing assessments of the company’s performance and broader market conditions affecting the energy…
AInvest Wire · 3h agoIPS prices share sale at 3,346 yen/share
AInvest Wire · 4h agoCentury Therapeutics: CNTY-813 ind submission remains on track for Q4 2026; initial clinical data anticipated in second half of 2027 - SEC filing
AInvest Wire · Oct 2, 2026Century Therapeutics - Increases board size to seven directors, appoints Joseph Truitt effective Sept 9, 2026 - SEC filing
AInvest Wire · Sep 9, 2026Century Therapeutics Q2 operating income USD -36.527 million vs. IBES estimate USD -24.5 million
AInvest Wire · Aug 12, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.